These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Results obtained with the clinical use of adriamycin]. Esposito S; Taylor LA Haematologica; 1971; 56(9):343-66. PubMed ID: 5004536 [No Abstract] [Full Text] [Related]
3. [Current therapy of malignant blood diseases]. de Werra P Praxis; 1967 Jun; 56(26):901-6. PubMed ID: 5253422 [No Abstract] [Full Text] [Related]
4. [Clinical research on the antipyretic effects of indomethacin in systemic hemopathies]. Marcolongo R; Bianco G; Di Paolo N; Bravi A Minerva Med; 1970 Oct; 61(82):4532-41. PubMed ID: 5273365 [No Abstract] [Full Text] [Related]
5. [Experience of use of bruneomycin in leukemia]. Krasovskiĭ II; Kudinov VG Antibiotiki; 1969 Jan; 14(1):77-81. PubMed ID: 5253409 [No Abstract] [Full Text] [Related]
6. Adrenal steroids in the treatment of malignant hematologic disease. Cline MJ Med Clin North Am; 1973 Sep; 57(5):1203-9. PubMed ID: 4205834 [No Abstract] [Full Text] [Related]
7. [What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases]. Havemann K; Schmidt M; Malchow H; Sodomann CP Internist (Berl); 1970 Dec; 11(12):441-9. PubMed ID: 4993105 [No Abstract] [Full Text] [Related]
8. Trenimon treatment in chronic hemoblastoses. Quattrin N; Dini E; Montuori R Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):145-52. PubMed ID: 4968994 [No Abstract] [Full Text] [Related]
9. The comparative value of several tests in predicting the response to chemotherapy in patients with malignant hemophathies. Cheţa D; Micu D; Cheţa N Med Interne; 1979; 17(4):353-7. PubMed ID: 390678 [No Abstract] [Full Text] [Related]
10. [Current status of cytostatic therapy]. Wilmanns W Wien Med Wochenschr; 1974 Nov; 124(48):699-707. PubMed ID: 4611049 [No Abstract] [Full Text] [Related]
12. [Experiences with intense cytostatic therapy of malignant tumors]. Siering H; Reinhardt M Arzneimittelforschung; 1968 Sep; 18(9):1182-91. PubMed ID: 4885374 [No Abstract] [Full Text] [Related]
13. [On the enzyme therapy of leukemias]. Schmidt CG; Gallmeier WM Dtsch Med Wochenschr; 1968 Nov; 93(48):2299-309. PubMed ID: 4880265 [No Abstract] [Full Text] [Related]
14. [Life expectancy of hemoblastosis patients]. Obrecht P Med Klin; 1966 Dec; 61(50):1985-90. PubMed ID: 5239386 [No Abstract] [Full Text] [Related]
15. Leukemia and lymphoma. White LP Geriatrics; 1970 Dec; 25(12):82-6. PubMed ID: 5274229 [No Abstract] [Full Text] [Related]
16. [Therapy of leukemia in USA. 2. L asparaginase in leukemia]. Böttiger LE Lakartidningen; 1969 Jan; 66(5):455-60. PubMed ID: 5254602 [No Abstract] [Full Text] [Related]
17. Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors. Clarkson B; Krakoff I; Burchenal J; Karnofsky D; Golbey R; Dowling M; Oettgen H; Lipton A Cancer; 1970 Feb; 25(2):279-305. PubMed ID: 4905154 [No Abstract] [Full Text] [Related]
18. [Rehabilitation and cure of patients with hemoblastoses]. Gerhartz H Dtsch Med J; 1968 Mar; 19(5):161-3. PubMed ID: 4887782 [No Abstract] [Full Text] [Related]
19. [Rubidomycine. A new antineoplastic antibiotic]. Soulié L Munch Med Wochenschr; 1968 Jun; 110(25):1539-41. PubMed ID: 5252222 [No Abstract] [Full Text] [Related]